Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2004
06/15/2004US6750238 Aralkyl ester soft drugs
06/15/2004US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
06/15/2004US6750232 2-aminopyridine compounds and use thereof as drugs
06/15/2004US6750231 Skin disorders; gastrointestinal disorders
06/15/2004US6750230 Pyrazole derivatives
06/15/2004US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions
06/15/2004US6750222 Substituted phenyl derivatives
06/15/2004US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis
06/15/2004US6750214 Quinoline and quinazoline compounds useful in therapy
06/15/2004US6750213 Bone disorders; urogenital system disorders; anticancer agents
06/10/2004WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes
06/10/2004WO2004048368A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
06/10/2004WO2004048367A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/10/2004WO2004048365A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
06/10/2004WO2004048348A1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) ones used as herbicides
06/10/2004WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/10/2004WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators
06/10/2004WO2004048332A1 Isoindoline derivative
06/10/2004WO2004047744A2 3-heterocyclic benzylamide derivatives as potassium channel openers
06/10/2004WO2004047739A2 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
06/10/2004WO2004047674A2 Oxyge-containing heterocyclic fused naphthopyrans
06/10/2004WO2004032845A3 R-nsaid esters and their use
06/10/2004WO2004028445A3 Processes for preparing 1,3-dioxolane nucleosides
06/10/2004WO2004018429A3 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/10/2004WO2003066005A3 Ansamycins having improved pharmacological and biological properties
06/10/2004WO2003059265A3 Compositions and methods for treating heart failure
06/10/2004US20040110957 producing racemic 3-hydroxy-3-(2-phenylethyl)-hexanoic acid at rapid reaction rates to form [R (R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide
06/10/2004US20040110956 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/10/2004US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide
06/10/2004US20040110949 Benzo[b]furan dimers
06/10/2004US20040110946 such as ethyl-2-[6-amino-4-(1,3-benzodioxol-5-yl)-3,5-dicyano-2-pyridinyl]propionate; drug screening; for treatment of cardiovascular disorders/diabetes
06/10/2004US20040110824 2-Phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
06/10/2004US20040110823 Bone disorders; cardiovascualr disorders; hormone replacement therapy
06/10/2004US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione
06/10/2004US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair
06/10/2004US20040110804 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment
06/10/2004US20040110802 Antibacterial benzoic acid derivatives
06/10/2004US20040110798 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders
06/10/2004US20040110793 Heterocyclo inhibitors of potassium channel function
06/10/2004US20040110779 Hydantoin derivsatives with affinity for somatostatin receptors
06/10/2004US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders
06/10/2004US20040110757 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
06/10/2004US20040110750 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment
06/10/2004US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
06/10/2004US20040110745 Serotonin (5-HT) receptor antagonists; psychiatric, eating , sexual, panic, psychological, gastrointestinal, cardiovascular, and sleep disorders; headaches, dementia
06/10/2004US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
06/10/2004US20040110741 Substituted pyrazolyl compounds for the treatment of inflammation
06/10/2004US20040110736 Cyclic derivatives as modulators of chemokine receptor activity
06/10/2004US20040110640 Herbicidal substituted benzoylpyrazoles
06/10/2004US20040110126 Hcv polymerase inhibitor assay
06/10/2004US20040107518 Mass coloration of substrates, as colorants in electrophotographic toners and developers, in powders and powder coating materials, in ink-jet inks and in cosmetic compositions; colorfastnessfast; heat and chemical resistance; azo-methine dyes
06/10/2004CA2506796A1 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
06/10/2004CA2502970A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/09/2004EP1426370A1 Propanolamine derivative having 1,4 benzodioxane ring
06/09/2004EP1426365A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
06/09/2004EP1426046A1 Novel use of tricyclic compound
06/09/2004EP1425011A2 Enhancement of learning and memory and treatment of amnesia
06/09/2004EP1425010A1 Substituted indoles and their use as integrin antagonists
06/09/2004EP1202966B1 Piperidine alcohols
06/09/2004EP1196412B1 Nitrogen containing heterobicycles as factor xa inhibitors
06/09/2004EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin
06/09/2004EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
06/09/2004EP1000039B1 Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
06/09/2004DE10255416A1 Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one Substituted 2-aryl-1,2,4-triazine-3,5-di (thi) ones
06/09/2004CN1503795A Water-soluble triazole fungicide
06/09/2004CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors
06/09/2004CN1503787A Novel compounds
06/09/2004CN1503786A Large conductance calcium-activated k channel opener
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/09/2004CN1503673A antiinflammation agents
06/09/2004CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
06/09/2004CN1152877C Piperazine derivatives
06/09/2004CN1152876C Substituted phenyl uracils compound
06/09/2004CN1152875C Oxyranyle-triazoline thiones and their use as microbicides
06/09/2004CN1152873C Novel diphenyl-piperidine derivate
06/09/2004CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof
06/09/2004CN1152860C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
06/09/2004CN1152859C Novel N-vinyllactam derivatives and polymer thereof
06/09/2004CN1152716C Farnesyl protein transferase inhbitors with internal radiosensitizing
06/08/2004US6747054 EP4 receptor selective agonists in the treatment of osteoporosis
06/08/2004US6747053 Heteroaryl nitriles
06/08/2004US6747048 Pyridine-based thyroid receptor ligands
06/08/2004US6747046 Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents
06/08/2004US6747045 Such as 1-(3-(((3,4-dihydro-2h-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1h)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders
06/08/2004US6747044 Neurokinin antagonists
06/08/2004US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia
06/08/2004US6747031 N-heterocyclic derivatives as NOS inhibitors
06/08/2004US6747025 Kinase inhibitors for the treatment of disease
06/08/2004US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals
06/08/2004US6747023 Sulfonyl derivatives
06/08/2004CA2307552C Substituted pyridine compounds as anti-inflammatory agents
06/03/2004WO2004046162A2 Non-steroidal fxr agonists
06/03/2004WO2004046139A1 Benzofuran derivates, process for their preparation and intermediates thereof
06/03/2004WO2004046133A1 Amino-heterocycles as vr-1 antagonists for treating pain
06/03/2004WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors
06/03/2004WO2004046120A2 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004WO2004046119A1 Substituted aralkyl derivatives
06/03/2004WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors
06/03/2004WO2004046113A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
06/03/2004WO2004046107A1 Indole derivatives as somatostatin agonists or antagonists